IRIS UniCatt

Mazzone, Elena Stacy
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.189
NA - Nord America 1.376
AS - Asia 1.293
SA - Sud America 236
AF - Africa 37
OC - Oceania 1
Totale 5.132
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.319
DE - Germania 1.083
SG - Singapore 600
NL - Olanda 367
CN - Cina 297
IT - Italia 270
BR - Brasile 190
VN - Vietnam 96
FR - Francia 92
SE - Svezia 90
GB - Regno Unito 62
IE - Irlanda 53
JP - Giappone 46
IN - India 45
HK - Hong Kong 40
ID - Indonesia 40
FI - Finlandia 33
RU - Federazione Russa 32
CA - Canada 31
PL - Polonia 28
KR - Corea 24
TR - Turchia 22
BD - Bangladesh 17
AR - Argentina 16
ES - Italia 16
PK - Pakistan 13
MX - Messico 11
ZA - Sudafrica 11
IQ - Iraq 9
PE - Perù 9
EC - Ecuador 8
AT - Austria 7
CO - Colombia 7
UA - Ucraina 7
IL - Israele 6
LT - Lituania 6
PH - Filippine 6
SA - Arabia Saudita 6
BG - Bulgaria 5
CZ - Repubblica Ceca 5
DK - Danimarca 5
DZ - Algeria 5
EG - Egitto 5
UZ - Uzbekistan 5
CH - Svizzera 4
IR - Iran 4
PA - Panama 4
TN - Tunisia 4
JM - Giamaica 3
LV - Lettonia 3
MA - Marocco 3
PT - Portogallo 3
PY - Paraguay 3
TH - Thailandia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
DO - Repubblica Dominicana 2
GR - Grecia 2
GT - Guatemala 2
HR - Croazia 2
KZ - Kazakistan 2
NG - Nigeria 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BY - Bielorussia 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
HT - Haiti 1
JO - Giordania 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
MG - Madagascar 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
RS - Serbia 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 5.132
Salva come PNG Salva come JPEG
Città #
Singapore 354
Amsterdam 350
Frankfurt am Main 341
Ashburn 211
San Jose 180
Chandler 108
New York 89
Hefei 77
Los Angeles 51
Beijing 49
Rome 49
Dublin 45
Tokyo 45
Dallas 44
Lauterbourg 39
Jakarta 38
Munich 38
Ho Chi Minh City 37
Hong Kong 37
Milan 32
Hanoi 27
Chicago 26
Seoul 24
Santa Clara 21
São Paulo 21
Kent 20
Warsaw 20
Council Bluffs 17
Helsinki 17
Boston 16
Moscow 15
Palermo 15
Denver 14
Nuremberg 14
Atlanta 13
Chennai 13
London 13
Turku 13
Houston 11
Poplar 11
Stockholm 11
Toronto 11
Düsseldorf 10
Marseille 10
Pune 10
Lima 9
Brooklyn 8
Buffalo 8
Johannesburg 8
Orem 8
Princeton 8
Ankara 7
Manchester 7
Phoenix 7
San Mateo 7
Secaucus 7
Boardman 6
Columbus 6
Falkenstein 6
Florence 6
Hangzhou 6
Istanbul 6
Montreal 6
San Francisco 6
Wilmington 6
Brasília 5
City of London 5
Curitiba 5
Mexico City 5
Naples 5
Shenzhen 5
Tashkent 5
The Dalles 5
Turin 5
Ancona 4
Edinburgh 4
Fairfield 4
Haiphong 4
Kiel 4
Mumbai 4
New Delhi 4
Quito 4
Rio de Janeiro 4
Shanghai 4
Sofia 4
Bern 3
Bremen 3
Brno 3
Bucaramanga 3
Busto Arsizio 3
Duque de Caxias 3
Faisalabad 3
Harrisburg 3
Hyderabad 3
Karachi 3
Kyiv 3
Lahore 3
Lappeenranta 3
Newark 3
Panama City 3
Totale 2.879
Salva come PNG Salva come JPEG
Nome #
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 946
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial 642
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial 266
Performance of Upper Limb module for Duchenne muscular dystrophy 233
Gain and loss of upper limb abilities in Duchenne muscular dystrophy patients: A 24-month study 154
Different trajectories in upper limb and gross motor function in spinal muscular atrophy 153
Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo-controlled, dose-finding trial followed by 24 months of treatment 143
Our Experience on Temporal Bone Fractures: Retrospective Analysis of 141 Cases 136
Emergencies cards for neuromuscular disorders 1st Consensus Meeting from UILDM - Italian Muscular Dystrophy Association Workshop report 128
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 125
Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53 124
2-Year Change in Revised Hammersmith Scale Scores in a Large Cohort of Untreated Paediatric Type 2 and 3 SMA Participants 123
Clinical Variability in Spinal Muscular Atrophy Type III. 113
Sleep disorders in spinal muscular atrophy 111
Revised upper limb module for spinal muscular atrophy: Development of a new module 109
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 104
Correction to: Two‑year efficacy and safety of risdiplam in patients with type 2 or non‑ambulant type 3 spinal muscular atrophy (SMA) 98
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy 98
Patient reported outcome measure for upper limb in Duchenne muscular dystrophy: correlation with PUL2.0 97
North Star Ambulatory Assessment changes in ambulant Duchenne boys amenable to skip exons 44, 45, 51, and 53: A 3 year follow up 97
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test 96
Old measures and new scores in spinal muscular atrophy patients 86
Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials 85
Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo-controlled, dose-finding trial followed by 24 months of treatment 81
Correction: Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53 (PLoS ONE (2019) 14:6 (e0218683) DOI: 10.1371/journal.pone.0218683) 77
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy 76
Erratum: Long term natural history data in ambulant boys with duchenne muscular dystrophy: 36-month changes (PLoS ONE (2015) 10:12 (e0144079)) 73
First international workshop on rehabilitation management and clinical outcome measures for spinal muscular atrophy 68
Hammersmith Functional Motor Scale and Motor Function Measure-20 in non ambulant SMA patients 67
Early neurodevelopmental assessment in Duchenne muscular dystrophy 66
Assessing upper limb function in nonambulant SMA patients: Development of a new module 59
Revised Hammersmith Scale for spinal muscular atrophy: A SMA specific clinical outcome assessment tool 53
Daily salbutamol in young patients with SMA type II 52
Spinal muscular atrophy functional composite score: A functional measure in spinal muscular atrophy 50
Correction: Long term natural history data in ambulant boys with duchenne muscular dystrophy: 36-Month changes 49
The Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): Test development and reliability 49
Development of a patient-reported outcome measure for upper limb function in Duchenne muscular dystrophy: DMD Upper Limb PROM 47
Reliability of the North Star Ambulatory Assessment in a multicentric setting 39
Totale 5.173
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.707
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.707
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 1 1 0
2021/202293 11 0 0 19 4 6 3 10 4 6 18 12
2022/2023359 19 30 26 44 30 59 17 34 51 12 20 17
2023/2024467 22 83 12 23 15 87 40 43 11 21 50 60
2024/2025852 22 15 82 25 60 53 47 34 82 69 209 154
2025/20263.400 267 68 177 321 470 1.419 339 98 130 111 0 0
Totale 5.173